Cerenome, Inc. (CNSY) Key Metrics
CNSY valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $12.9M
- Enterprise value
- $6.3M
- P/E (TTM)
- —
- Forward P/E
- 1.0
- PEG ratio
- 2.45
- Price / sales
- 3.1
- Price / book
- 2.8
- EV / EBITDA
- 29.1
- Dividend yield
- —
- Beta
- 1.47
CNSY key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsCNSY returns How much profit the business earns on the capital it uses.
Return on assets−51.0 pts
−195.0%
2025 · hover or tap a bar for each year
20162025
Free cash flow margin−216.1 pts
−399.8%
2025 · hover or tap a bar for each year
20162025
Asset turnover−29.7%
0.45
2025 · hover or tap a bar for each year
20162025
CNSY financial health Debt, liquidity and how easily interest is covered.
Debt / equity
0.21
2025 · hover or tap a bar for each year
20162025
Net debt−$7.7M
−$7.9M
2025 · hover or tap a bar for each year
20162025
Current ratio+264.3%
1.23
2025 · hover or tap a bar for each year
20162025
Interest coverage
-4.2
2025 · hover or tap a bar for each year
20162025
Debt / assets−90.1%
0.05
2025 · hover or tap a bar for each year
20162025
CNSY efficiency & capital use Working capital cycle and where the cash goes.
Days payables outstanding+2,180 days
5,229 days
2025 · hover or tap a bar for each year
20162025
Capex / revenue−1.2 pts
1.3%
2025 · hover or tap a bar for each year
20162025
CNSY valuation history
Fiscal year-endToday10-year median
CNSY returns on capital
ROEROICROA
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
CNSY debt vs cash
Total debtCash & short-term investments
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
CNSY cash returned to shareholders
DividendsBuybacksFree cash flow
CNSY price vs earnings per share
Share price at year-endEPS (right axis)
CNSY key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Market capitalization | $39.7M | — | — | — | — | — | — | — | — | — |
| Enterprise value | $31.7M | — | — | — | — | — | — | — | — | — |
| Price / sales | 7.6 | — | — | — | — | — | — | — | — | — |
| Price / book | 9.9 | — | — | — | — | — | — | — | — | — |
| EV / sales | 6.1 | — | — | — | — | — | — | — | — | — |
| Earnings yield | −56.4% | — | — | — | — | — | — | — | — | — |
| Free cash flow yield | −52.5% | — | — | — | — | — | — | — | — | — |
| Shareholder yield (dividends + buybacks) | 0.0% | — | — | — | — | — | — | — | — | — |
| Share price at fiscal year-end | $12.75 | $28.75 | $43.75 | $120.00 | $393.75 | $757.50 | $900.00 | $5,437.50 | $56,250.00 | $283,125.00 |
| Per share | ||||||||||
| Revenue per share | $1.68 | — | — | — | — | — | — | — | — | — |
| Earnings per share | −$7.19 | — | — | — | — | — | — | — | — | — |
| Operating cash flow per share | −$6.68 | — | — | — | — | — | — | — | — | — |
| Free cash flow per share | −$6.70 | — | — | — | — | — | — | — | — | — |
| Cash per share | $2.81 | — | — | — | — | — | — | — | — | — |
| Book value per share | $1.28 | — | — | — | — | — | — | — | — | — |
| Tangible book value per share | $1.06 | — | — | — | — | — | — | — | — | — |
| Capex per share | $0.02 | — | — | — | — | — | — | — | — | — |
| Debt per share | $0.26 | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 3.1M | — | — | — | — | — | — | — | — | — |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | — | — | — | −234.7% | −193.3% | −393.3% | −341.0% | −138.6% | −189.2% | −834.4% |
| Return on invested capital (ROIC) | — | — | — | — | — | — | — | −44.3% | −98.6% | −147.3% |
| Return on assets (ROA) | −195.0% | −144.0% | −75.5% | −88.4% | −78.6% | −46.6% | −46.1% | −45.4% | −68.5% | −60.1% |
| Return on tangible assets | −143.3% | −224.1% | −121.3% | −86.6% | −62.2% | −70.8% | −47.6% | −53.5% | −110.7% | −99.1% |
| Free cash flow margin | −399.8% | −183.7% | −264.8% | — | — | — | −85.4% | −405.9% | −306.1% | −172.2% |
| Financial health | ||||||||||
| Total debt | $821,000 | $3.4M | $4.2M | $5.8M | $7.0M | $7.0M | $12.0M | $14.2M | $13.6M | $17.6M |
| Cash & short-term investments | $8.8M | $3.6M | $8.6M | $18.1M | $18.4M | $8.3M | $17.6M | $5.3M | $9.6M | $12.6M |
| Net debt | −$7.9M | −$239,000 | −$4.4M | −$12.4M | −$11.4M | −$1.4M | −$5.6M | $8.9M | $4.1M | $5.1M |
| Debt / equity | 0.21 | — | — | 0.89 | 0.65 | 2.31 | 10.32 | 2.72 | 1.05 | 1.61 |
| Debt / assets | 0.05 | 0.51 | 0.37 | 0.24 | 0.32 | 0.58 | 0.52 | 0.59 | 0.43 | 0.51 |
| Current ratio | 1.23 | 0.34 | 0.92 | 1.84 | 3.36 | 1.07 | 1.37 | 0.55 | 0.81 | 1.50 |
| Quick ratio | 1.23 | 0.34 | 0.92 | 1.84 | 3.36 | 1.07 | 1.36 | 0.54 | 0.63 | 1.20 |
| Interest coverage | -4.2 | -3.9 | -33.7 | -27.7 | -13.4 | -8.7 | -2.0 | -4.6 | -10.1 | -7.6 |
| Working capital | $2.9M | −$10.3M | −$893,000 | $10.0M | $13.9M | $636,000 | $5.3M | −$7.9M | −$3.5M | $6.2M |
| Invested capital | −$3.9M | −$9.2M | −$5.7M | −$5.9M | −$571,000 | $1.7M | −$4.4M | $14.2M | $17.1M | $16.1M |
| Tangible asset value | $3.3M | −$9.8M | −$1.8M | $6.0M | $10.4M | $2.6M | $788,000 | $4.9M | $1.9M | −$1.4M |
| Net current asset value | $2.8M | −$10.3M | −$2.9M | $4.4M | $8.6M | $101,000 | −$2.2M | −$9.1M | −$3.8M | −$4.9M |
| Graham net-net per share | −$1.15 | — | — | — | — | — | — | — | — | — |
| Capital allocation | ||||||||||
| Dividends paid | — | — | — | — | — | — | — | — | — | $75,000 |
| Share buybacks (net) | $0 | $374,000 | $126,000 | $0 | — | — | — | — | $2.1M | — |
| Capex / revenue | 1.3% | 2.5% | 3.3% | 338.8% | — | 162.7% | 1.0% | 4.5% | 23.3% | 0.6% |
| Capex / depreciation | 0.15 | 0.17 | 0.25 | 1.23 | 0.36 | 1.35 | 0.07 | 0.07 | 0.70 | 0.06 |
| Stock-based compensation / revenue | 29.5% | 9.4% | 11.6% | 270.5% | — | 81.5% | 1.8% | 11.9% | 11.7% | 9.5% |
| R&D / revenue | 160.7% | 181.7% | 197.2% | 4,329.5% | — | 1,148.8% | 76.7% | 185.1% | 208.5% | 142.3% |
| SG&A / revenue | 232.7% | 170.7% | 173.9% | 4,570.5% | — | 2,114.2% | 75.6% | 187.0% | 174.5% | 107.0% |
| Efficiency | ||||||||||
| Days sales outstanding | — | 35.8 | — | — | — | 826.4 | 40.3 | 30.0 | 44.1 | 42.5 |
| Days of inventory on hand | — | — | — | — | — | — | — | 523.0 | 956.5 | 575.0 |
| Days payables outstanding | 5,228.9 | 3,048.5 | 247.1 | 2,813.1 | 9,401.5 | 75.4 | — | 320.8 | 364.0 | 153.3 |
| Cash conversion cycle (days) | — | -3,012.7 | — | — | — | 750.9 | — | 232.2 | 636.6 | 464.2 |
| Receivables turnover | — | 10.20 | — | — | 0.00 | 0.44 | 9.05 | 12.18 | 8.27 | 8.58 |
| Payables turnover | 0.07 | 0.12 | 1.48 | 0.13 | 0.04 | 4.84 | 0.00 | 1.14 | 1.00 | 2.38 |
| Inventory turnover | — | — | — | — | — | — | 0.00 | 0.70 | 0.38 | 0.63 |
| Asset turnover | 0.45 | 0.65 | 0.28 | 0.01 | 0.00 | 0.02 | 0.30 | 0.11 | 0.19 | 0.31 |
| Average receivables | — | $571,000 | — | — | $33,000 | $686,000 | $773,000 | $245,000 | $775,000 | $1.3M |
| Average payables | $6.4M | $7.1M | $6.6M | $5.5M | $1.7M | $558,000 | $524,000 | $1.0M | $1.3M | $1.1M |
| Average inventory | — | — | — | — | — | — | $107,000 | $1.6M | $3.5M | $4.3M |
| Intangibles / total assets | 4.3% | 12.7% | 3.6% | 2.0% | 1.9% | 3.8% | 1.6% | 1.6% | 35.2% | 35.7% |
Computed from CNSY's annual financial statements (latest annual report filed March 12, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
CNSY valuation and financial ratios
It ended the year with $0.8 million of debt and $8.8 million in cash and short-term investments, a net cash position of $7.9 million.
See the CNSY income statement, the CNSY chart for price history, or the CNSY stock overview for the latest quote and news.
CNSY key metrics FAQ
How much debt does Cerenome have?
Cerenome had total debt of $0.8 million at the end of fiscal 2025, a debt-to-equity ratio of 0.21 and more cash than debt.
What is Cerenome's free cash flow yield?
Cerenome generated -$20.8 million of free cash flow in fiscal 2025, a free cash flow yield of −52.5% on its market value at year-end ($39.7 million).
What is Cerenome's current ratio?
Cerenome's current ratio was 1.23 at the end of fiscal 2025: current assets were 1.23 times current liabilities.